KIT and neoplasm: Different kinds of VEGF TKIs have certain unique characteristics including activity against TK domains of several other receptors involved in tumor proliferation such as c-Kit, Raf, PDGF, and FGF, and this can lead to the selective inhibition of new vessel growth and decreased vascular perfusion and permeability in tumors.